Physician profile
Clayton Patrick
NPI 1750812194
$3,099.94
in general payments reported to CMS, 2019-2025
18 companies · $646 in 2025
The $646 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2021: $366 · 2022: $613 · 2023: $429 · 2024: $585 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,660.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $908.54 | 2019-2024 | Clareon, Wavelight Refractive Suite |
| Sight Sciences, INC. | $329.68 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument, Tearcare System |
| Abbvie INC. | $246.98 | 2022-2025 | |
| Glaukos Corporation | $220.14 | 2023-2025 | Idosetr, Kxl System (Not Refurbished) |
| Allergan, INC. | $197.06 | 2022 | |
| Dompe US, INC. | $182.61 | 2024-2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $145.79 | 2024-2025 | Acthar |
| Biotissue Holdings INC. | $139.56 | 2023-2025 | |
| Ocular Therapeutix, INC. | $133.54 | 2022-2024 | Dextenza |
| Tarsus Pharmaceuticals, INC. | $129.61 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $113.48 | 2023-2024 | Tecnis Iol, Tecnis Simplicity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.05 | 2019 | |
| Bausch & Lomb Americas INC. | $72.87 | 2023-2024 | Xiidra, Infuse, Miebo |
| Sun Pharmaceutical Industries INC. | $46.77 | 2022 | |
| Rayner Intraocular Lenses Limited | $45.91 | 2023 | Rayone Aspheric, Rayone Emv, Omidria |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $37.99 | 2024 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Vision Care, INC. | $27.24 | 2022-2023 | Acuvue |
| Rxsight INC | $23.12 | 2022-2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.